E-LIB Suche - Ergebnisse für: van der Ende, Jacob

1

Leishmania Animal Models Used in Drug Discovery: A Systemat..:

van der Ende, Jacob ; Schallig, Henk D. F. H.
Animals. 13 (2023) 10 - p. 1650 , 2023

Link: https://doi.org/10.3390/..

2

Safety and efficacy of allylamines in the treatment of cuta..:

Bezemer, Jacob M. ; van der Ende, Jacob ; Limpens, Jacqueline...
PLOS ONE. 16 (2021) 4 - p. e0249628 , 2021

Link: https://doi.org/10.1371/..

3

A Modified Case Definition to Facilitate Essential Hospital..:

Huizenga, Erdi ; van der Ende, Jacob ; Zwinkels, Nick...
Clinical Infectious Diseases. 68 (2018) 10 - p. 1763-1768 , 2018

Link: https://doi.org/10.1093/..

4

Circulating bone morphogenetic protein levels and delayed f..:

van Baardewijk, Laurens J. ; van der Ende, Jacob ; Lissenberg-Thunnissen, Suzanne...
International Orthopaedics. 37 (2012) 3 - p. 523-527 , 2012

Link: https://doi.org/10.1007/..

5

Circulating bone morphogenetic protein levels and delayed f..:

van Baardewijk, Laurens J ; van der Ende, Jacob ; Lissenberg-Thunnissen, Suzanne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580113. , 2012

Link: http://www.ncbi.nlm.nih...

6

Leishmania Animal Models Used in Drug Discovery: A Systemat..:

Jacob van der Ende ; Henk D. F. H. Schallig
Animal Welfare. , 2023

Link: https://doi.org/10.3390/..

7

Leishmania Animal Models Used in Drug Discovery: A Systemat..:

Jacob van der Ende ; Henk D. F. H. Schallig
https://www.mdpi.com/2076-2615/13/10/1650. , 2023

Link: https://doi.org/10.3390/..

8

Safety and efficacy of allylamines in the treatment of cuta..:

Jacob M Bezemer ; Jacob van der Ende ; Jacqueline Limpens..
https://doi.org/10.1371/journal.pone.0249628. , 2021

Link: https://doi.org/10.1371/..

9

Calidad de vida en niños y adultos después de cirugía para ..:

Aguilar-Alaníz, Elizabeth ; Reyes-Pavón, Rodrigo ; Van-der-Ende, Jacob...
Archivos de Cardiología de México. 91 (2021) 1 - p. , 2021

Link: https://doi.org/10.24875..

10

Results of in vitro and clinical studies on the combination..:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/dataset/Results_of_i_in_vitro_i_and_clinical_studies_on_the_combination_of_terbinafine_with_other_treatment_in_cutaneous_and_mucocutaneous_leishmaniasis_/14384395. , 2021

Link: https://doi.org/10.1371/..

11

Characteristics of in vitro studies reporting on effects of..:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/dataset/Characteristics_of_i_in_vitro_i_studies_reporting_on_effects_of_allylamines_in_cutaneous_and_mucocutaneous_leishmania_species_/14384389. , 2021

Link: https://doi.org/10.1371/..

12

Characteristics of case reports:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/journal_contribution/Characteristics_of_case_reports_/14384362. , 2021

Link: https://doi.org/10.1371/..

13

PRISMA literature assessment flow diagram:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/figure/PRISMA_literature_assessment_flow_diagram_/14384371. , 2021

Link: https://doi.org/10.1371/..

14

Risk of Bias assessment of animal trials:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/figure/Risk_of_Bias_assessment_of_animal_trials_/14384380. , 2021

Link: https://doi.org/10.1371/..

15

Overview of clinical and in vitro Leishmania species specif..:

Jacob M. Bezemer (10536364) ; Jacob van der Ende (10536367) ; Jacqueline Limpens (5574186)..
https://figshare.com/articles/dataset/Overview_of_clinical_and_i_in_vitro_Leishmania_i_species_specific_results_of_terbinafine_in_cutaneous_leishmaniasis_/14384392. , 2021

Link: https://doi.org/10.1371/..